Article

Fewer Joint Surgeries With Recent RA Diagnosis

Better rheumatoid arthritis treatments may be reducing the need for potentially dangerous joint replacements, say Mayo Clinic researchers.

For patients who recently received a diagnosis of rheumatoid arthritis (RA), the rates of arthritis-related joint surgery continue to decrease, according to researchers in the departments of medicine and health sciences research at the Mayo Clinic College of Medicine. The investigators also found that joint reconstructive procedures (JRP) are associated with increased mortality.

Shourt and associates performed a retrospective medical record review of orthopedic surgeries after diagnosis in cases of adult-onset RA in 1980-2007. Surgeries included primary total joint arthroplasty, JRP, soft tissue procedures (STP), and revision arthroplasty.

The cumulative incidence of any joint surgery at 10 years after RA incidence for the 1980-1994 cohort was 27.3%, compared with 19.5% for the 1995-2007 cohort. The greatest reduction was in STP. Women had more surgery than men, and obese patients had more surgery than nonobese patients. Mortality was significantly higher in patients who required JRP than in those who did not require the procedures.

The findings may reflect improved treatments for patients with RA as well as a continued higher disease burden among some patients, the investigators noted. The study was published online in the Journal of Rheumatology.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.